1. Home
  2. ASMB vs TRX Comparison

ASMB vs TRX Comparison

Compare ASMB & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASMB
  • TRX
  • Stock Information
  • Founded
  • ASMB 2005
  • TRX 1990
  • Country
  • ASMB United States
  • TRX Canada
  • Employees
  • ASMB N/A
  • TRX N/A
  • Industry
  • ASMB Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • ASMB Health Care
  • TRX
  • Exchange
  • ASMB Nasdaq
  • TRX Nasdaq
  • Market Cap
  • ASMB 84.5M
  • TRX 92.1M
  • IPO Year
  • ASMB 2010
  • TRX N/A
  • Fundamental
  • Price
  • ASMB $10.92
  • TRX $0.32
  • Analyst Decision
  • ASMB Buy
  • TRX Strong Buy
  • Analyst Count
  • ASMB 2
  • TRX 2
  • Target Price
  • ASMB $35.00
  • TRX $1.63
  • AVG Volume (30 Days)
  • ASMB 29.4K
  • TRX 382.3K
  • Earning Date
  • ASMB 03-27-2025
  • TRX 04-11-2025
  • Dividend Yield
  • ASMB N/A
  • TRX N/A
  • EPS Growth
  • ASMB N/A
  • TRX N/A
  • EPS
  • ASMB N/A
  • TRX 0.01
  • Revenue
  • ASMB $28,326,000.00
  • TRX $44,282,000.00
  • Revenue This Year
  • ASMB $282.16
  • TRX $68.64
  • Revenue Next Year
  • ASMB N/A
  • TRX $22.37
  • P/E Ratio
  • ASMB N/A
  • TRX $55.38
  • Revenue Growth
  • ASMB N/A
  • TRX 16.51
  • 52 Week Low
  • ASMB $10.56
  • TRX $0.28
  • 52 Week High
  • ASMB $19.93
  • TRX $0.49
  • Technical
  • Relative Strength Index (RSI)
  • ASMB 33.39
  • TRX 44.39
  • Support Level
  • ASMB $10.56
  • TRX $0.29
  • Resistance Level
  • ASMB $13.07
  • TRX $0.34
  • Average True Range (ATR)
  • ASMB 0.72
  • TRX 0.01
  • MACD
  • ASMB -0.09
  • TRX 0.00
  • Stochastic Oscillator
  • ASMB 15.44
  • TRX 25.50

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two innovative platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. Its projects include the Buckreef project, and Itetemia Gold project whereas, its exploration stage project consists of the Lunguya project and the Luhala project.

Share on Social Networks: